Li YP - Search Results

1

Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.

Li YP, Chen JJ, Shen JJ, Cui J, Wu LZ, Wang Z, Li ZR. Li YP, et al. Among authors: li zr. Cancer Chemother Pharmacol. 2015 Apr;75(4):773-82. doi: 10.1007/s00280-015-2696-9. Epub 2015 Feb 14. Cancer Chemother Pharmacol. 2015. PMID: 25681003

2

[Synthesis and neuroprotective activity in cell culture of aminoadamantane analogues].

Li YP, Li ZR, Cao J, Tao YJ. Li YP, et al. Among authors: li zr. Yao Xue Xue Bao. 2007 Apr;42(4):392-5. Yao Xue Xue Bao. 2007. PMID: 17633206 Chinese.

3

Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.

Tang YB, Peng ZG, Liu ZY, Li YP, Jiang JD, Li ZR. Tang YB, et al. Among authors: li yp, li zr. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6350-3. doi: 10.1016/j.bmcl.2007.08.065. Epub 2007 Aug 31. Bioorg Med Chem Lett. 2007. PMID: 17888662

4

Synthesis and biological evaluation of heat-shock protein 90 inhibitors: geldanamycin derivatives with broad antiviral activities.

Li YP, Shan GZ, Peng ZG, Zhu JH, Meng S, Zhang T, Gao LY, Tao PZ, Gao RM, Li YH, Jiang JD, Li ZR. Li YP, et al. Among authors: li yh, li zr. Antivir Chem Chemother. 2010 Aug 11;20(6):259-68. doi: 10.3851/IMP1631. Antivir Chem Chemother. 2010. PMID: 20710066 Free article.

5

A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells.

Shan GZ, Peng ZG, Li YH, Li D, Li YP, Meng S, Gao LY, Jiang JD, Li ZR. Shan GZ, et al. Among authors: li yh, li d, li yp, li zr. J Antibiot (Tokyo). 2011 Feb;64(2):177-82. doi: 10.1038/ja.2010.161. Epub 2010 Dec 22. J Antibiot (Tokyo). 2011. PMID: 21179047

6

Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus.

Peng ZG, Zhao ZY, Li YP, Wang YP, Hao LH, Fan B, Li YH, Wang YM, Shan YQ, Han YX, Zhu YP, Li JR, You XF, Li ZR, Jiang JD. Peng ZG, et al. Among authors: li yh, li yp, li jr, li zr. Hepatology. 2011 Apr;53(4):1080-9. doi: 10.1002/hep.24160. Hepatology. 2011. PMID: 21480314

7

Synthesis and antiviral activity of substituted bisaryl amide compounds as novel influenza virus inhibitors.

Hao LH, Li YP, He WY, Wang HQ, Shan GZ, Jiang JD, Li YH, Li ZR. Hao LH, et al. Among authors: li yh, li yp, li zr. Eur J Med Chem. 2012 Sep;55:117-24. doi: 10.1016/j.ejmech.2012.07.008. Epub 2012 Jul 14. Eur J Med Chem. 2012. PMID: 22824205

8

LC-MS/MS method for determination of geldanamycin derivative GM-AMPL in rat plasma to support preclinical development.

Li YP, Gao LY, Li KT, Meng S, Zhu JH, Li D, Jin J, Shan GZ, Li ZR. Li YP, et al. Among authors: li d, li zr, li kt. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jan 1;912:43-9. doi: 10.1016/j.jchromb.2012.09.002. Epub 2012 Nov 6. J Chromatogr B Analyt Technol Biomed Life Sci. 2013. PMID: 23261821

9

Synthesis and antiviral activity of N-phenylbenzamide derivatives, a novel class of enterovirus 71 inhibitors.

Ji XY, Wang HQ, Hao LH, He WY, Gao RM, Li YP, Li YH, Jiang JD, Li ZR. Ji XY, et al. Among authors: li yh, li yp, li zr. Molecules. 2013 Mar 21;18(3):3630-40. doi: 10.3390/molecules18033630. Molecules. 2013. PMID: 23519203 Free PMC article.

10

Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents.

Jiang Z, Wang H, Li Y, Peng Z, Li Y, Li Z. Jiang Z, et al. Acta Pharm Sin B. 2015 May;5(3):201-9. doi: 10.1016/j.apsb.2015.03.013. Epub 2015 Apr 8. Acta Pharm Sin B. 2015. PMID: 26579447 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,884 results

Search Page

Filters